• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
2019 Parkinson’s Disease Therapeutics Industry - Latest Report
 

2019 Parkinson’s Disease Therapeutics Industry - Latest Report

on

  • 275 views

The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s disease (PD) market is dominated ...

The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life.

Statistics

Views

Total Views
275
Views on SlideShare
275
Embed Views
0

Actions

Likes
1
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    2019 Parkinson’s Disease Therapeutics Industry - Latest Report 2019 Parkinson’s Disease Therapeutics Industry - Latest Report Presentation Transcript

    • Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management by GBI Research Explore all reports for “Parkinson Disease Drugs” market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/diseases-treatment/parkinsondisease-drugs. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management The collection of ‘Parkinson Disease Drugs’ market research reports has a new addition of “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management” on RnRMarketResearch.com . The Latest pharma report – “Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management”. The Parkinson’s disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD. Levodopa has remained the gold standard treatment for almost 40 years and has significantly improved patient quality of life. There is currently there is a huge unmet need for disease-modifying treatments that slow progression or have neuroprotective properties. Over the 2012–2019 forecast periods, the PD market is anticipated to decline from $3.4 billion in 2012 to $2.9 billion in 2019, as a consequence of upcoming patent expirations of high-profile products such as Azilect, Stalevo and Comtan. Although a few market entrants are anticipated to enter the market over the forecast period, they are not expected to offset the impact of generic erosion. Request a sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=136892. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management Despite their superior profiles over existing treatments, these new products are not expected to command a premium price as they will be competing against generic products. The current PD pipeline reflects a shift of focus to long-term PD management, marked by the development of key pipeline candidates targeting levodopa-associated motor complications. These products will have the potential to change the future treatment algorithm as side effects of dopaminergic therapies become more manageable. Scope A brief introduction to PD, including pathogenesis, disease staging, diagnosis and treatment algorithms In-depth analysis of the drugs available for the treatment of PD, covering their safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat map comparing drugs in terms of safety and efficacy Complete report available @ http://www.rnrmarketresearch.com/parkinsons-disease-therapeutics-marketto-2019-pipeline-shows-shift-towards-long-term-disease-management-marketreport.html. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Parkinson’s Disease Therapeutics Market to 2019 – Pipeline Shows Shift towards Long Term Disease Management For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441